LAUREN KING: Open Payments
NPI 1356690077 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 34 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $276 · 2025 $627
Food & beverage: $527Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $274 |
| Amgen Inc. | 4 | $62 |
| Galderma Laboratories, L.P. | 2 | $49 |
| ABBVIE INC. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| GENZYME CORPORATION | 1 | $32 |
| PFIZER INC. | 2 | $31 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| LEO Pharma Inc. | 1 | $27 |
Products named: TREMFYA, OTEZLA, NEMLUVIO, SKYRIZI, LIBTAYO, DUPIXENT, CIBINQO, POTELIGEO.
Industry payments across AZ — which companies pay providers there.
